Overview

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study evaluated the 1 year safety, tolerability and efficacy of indacaterol against placebo in the treatment of Chronic Obstructive Pulmonary Disease (COPD) patients
Phase:
Phase 3
Details
Lead Sponsor:
Novartis